How to Buy Surmodics Stock
Surmodics Inc
Surmodics, Inc. , together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally.
Surmodics stock last closed at $25.85, down 1.22% from the previous day, and has increased 12.44% in one year. It has overperformed other stocks in the Medical Devices industry by 0.28 percentage points. Surmodics stock is currently +53.96% from its 52-week low of $16.79, and -34.41% from its 52-week high of $39.41.
At the moment, there are 14.24M shares of SRDX outstanding. The market cap of SRDX is $368.00M. In the last 24 hours, 23,946 SRDX shares were traded.
How to Buy Surmodics Stock
Wondering how to invest in Surmodics stock? Here's how.
- Choose where to buy Surmodics stock: You need to choose an online brokerage, but don't worry - we've analyzed dozens of stock brokerages and apps to help you figure out where to buy Surmodics stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Fund your brokerage account: Pick your payment method and add your details.
- Evaluate Surmodics stock: The Surmodics ticker symbol is SRDX. Is Surmodics stock a good investment? Should you buy shares of SRDX? How do SRDX's underlying business fundamentals look? Do top analysts think Surmodics is a good buy? Why has SRDX's stock price moved recently? (Hint: Our stock market research tools can help you figure out if SRDX is a good stock to buy).
- Place your SRDX buy order: Decide if you will purchase SRDX shares at the current market price or use a limit order to buy SRDX stock at a specific price.
- Get updates on your SRDX position: Create a watchlist to important notifications about your investment in Surmodics stock.
Step 1: Choose where to buy Surmodics stock
You need a brokerage account to access the NASDAQ market and buy SRDX stock.
Our preferred brokerage: eToro
Based on our experience, eToro is the best place to buy stocks. Here's why:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to global markets: From Tech to Real Estate, New York to Shanghai — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by signing up for an account with eToro now.
Open eToro AccountStep 2: Open your brokerage account
Now that you've selected your brokerage, you'll need to fill out some personal info so you can invest in SRDX stock today.
How to Start a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to open your new trading account.
- Submit your details by hitting the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you have finished signing up on the best stock trading app, you need to deposit funds:
Check out the tutorial below if you need help transferring money into your brokerage account.
Step 4: Evaluate Surmodics stock
After you have figured out the best place to buy Surmodics stock, it's important to evaluate their stock before you buy, so you actually comprehend the risk as well as the opportunity.
Surmodics stock data
Surmodics Zen Score
WallStreetZen was built to help everyday investors do better fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on SRDX's stock page.
Is SRDX stock properly valued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge SRDX's intrinsic value.
Using relative valuations measures:
- SRDX may be overvalued based on its P/E ratio of 66.28x, relative to Medical Devices industry P/E ratio of 27.9x
- SRDX could be undervalued based on its P/B ratio of 3.01x, relative to Medical Devices industry P/B ratio of 3.73x
You can do additional valuation research on SRDX's stock here.
A look at SRDX Cashflows and Balance Sheet
Passed Health Checks:
- SRDX profit margin has gone up from -31.7% to 4% in the past year.
- There are more short-term assets than long-term liabilities on the SRDX balance sheet.
- There are more short-term assets than short-term liabilities on the SRDX balance sheet.
- SRDX's operating cash flow of $12.52M allows it to safely service it's debt of $29.44M.
Failed Health Checks:
- SRDX has a relatively high debt to equity ratio of 0.48.
- Total SRDX debt is higher than 5 years ago, relative to shareholder equity.
- SRDX earnings of $13.33M is not sufficient to cover its interest payments.
Is it a good time to buy Surmodics stock, according to analysts?
Out of 2 Equities analysts who give forecasts on SRDX, the consensus analyst rating on Surmodics is a Buy
It's important to note that analyst ratings are not recommendations, nor are they investment advice.
You can dive deeper into what analysts are saying on the Surmodics stock forecast page.
SRDX Technical Indicators
Is SRDX Growing Revenue?
Last year, SRDX earnings were $5.52M. Over the last four year, SRDX's earnings have grown by -5.06% per year. This was slower than the Medical Devices industry average of 8.5%.
Last year, SRDX revenue was $138.20M. In the last 5 year, SRDX's revenue has grown by 9.81% per year. This was slower than the Medical Devices industry average of 13.19%.
Learn more about SRDX's earnings and revenue performance here.
What are SRDX insiders up to?
In the past year, executives and large shareholders at SRDX have sold more shares than they have bought.
Jose H. Bedoya, Director of SRDX, was the latest SRDX insider to sell. They sold $94,203.06 worth of SRDX stock on Feb 8, 2024.
Get more info about who owns SRDX shares here.
Does SRDX provide a stable income stream?
No, Surmodics doesn't provide an income stream by paying out dividends.
What do other traders have to say about SRDX?
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Place your SRDX buy order
You have two primary options:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are usually fine for most investors. - Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a specific price limit, place a limit order.
Click the Open Trade button and your broker will execute your order.
If you need additional info about investing in stocks on eToro, click the helpful video below:
Step 6: Get updates on your SRDX position
Now that you own some shares in SRDX, you'll want to keep up with your company.
Make a watchlist to track the most important metrics related to your SRDX stock.
SRDX Feed
How to Buy Stock in Surmodics
To reiterate, here are the 6 steps for buying Surmodics stock:
- Choose where to buy Surmodics stock
- Open your brokerage account
- Fund your brokerage account
- Evaluate Surmodics stock
- Place your SRDX buy order
- Get updates on your SRDX position
If you need a online brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to get updates on your new investment in Surmodics, add SRDX to your watchlist below.
Trending "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.